Quality Agreement

Quality Agreement designates a formal documented contract between parties including manufacturers, contract organisations, suppliers, or distributors defining quality-related responsibilities, procedures, communication protocols, and standards ensuring products and services meet quality requirements. These legally binding documents specify each party's obligations regarding GMP compliance, testing responsibilities, documentation requirements, deviation handling, change control, audit rights, and regulatory obligations.

The biopharmaceutical industry establishes quality agreements for diverse relationships including contract manufacturing organisations producing drug substance or product, analytical testing laboratories conducting release or stability testing, raw material suppliers providing critical components, and distributors handling product storage and shipping. Agreement content addresses technical requirements specifying manufacturing standards, testing methods, and specifications. Roles and responsibilities clearly delineate which party performs specific activities and maintains documentation. Communication protocols establish contacts, notification requirements, and escalation procedures. Change control defines processes for managing changes potentially affecting product quality. Regulatory inspections examine quality agreements assessing adequacy and compliance. As outsourcing increases, supply chains globalise, and regulatory expectations rise, quality agreements continue as essential tools ensuring clear understanding of quality responsibilities across complex pharmaceutical supply networks.